{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:26:26Z","timestamp":1793107586410,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ygyno.2023.01.012","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T04:41:06Z","timestamp":1674621666000},"page":"167-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Assessing the need for venous thromboembolism prophylaxis at the time of neoadjuvant chemotherapy for ovarian cancer: A literature review"],"prefix":"10.1016","volume":"170","author":[{"given":"Sara","family":"Moufarrij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dib","family":"Sassine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derman","family":"Basaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.","family":"Jewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2023.01.012_bb0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/AOG.0000000000001492","article-title":"Venous thromboembolism in minimally invasive compared with open hysterectomy for endometrial cancer","volume":"128","author":"Barber","year":"2016","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.01.012_bb0010","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejogrb.2013.06.004","article-title":"Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survival","volume":"170","author":"Saadeh","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.01.012_bb0015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ygyno.2006.08.026","article-title":"Thromboembolic complications in patients with clear cell carcinoma of the ovary","volume":"104","author":"Matsuura","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.01.012_bb0020","first-page":"2374716","article-title":"Meta-analysis of VTE risk: ovarian cancer patients by stage, histology, cytoreduction, and ascites at diagnosis","author":"Weeks","year":"2020","journal-title":"Obstet. Gynecol. Int."},{"issue":"2 Suppl","key":"10.1016\/j.ygyno.2023.01.012_bb0025","doi-asserted-by":"crossref","first-page":"7s","DOI":"10.1378\/chest.1412S3","article-title":"Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ygyno.2023.01.012_bb0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7410","article-title":"Safety and efficacy of apixaban vs enoxaparin for preventing postoperative venous thromboembolism in women undergoing surgery for gynecologic malignant neoplasm: a randomized clinical trial","volume":"3","author":"Guntupalli","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"7","key":"10.1016\/j.ygyno.2023.01.012_bb0035","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/jth.14149","article-title":"Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis","volume":"16","author":"Di Nisio","year":"2018","journal-title":"J. Thromb. and Haemost."},{"issue":"42","key":"10.1016\/j.ygyno.2023.01.012_bb0040","doi-asserted-by":"crossref","first-page":"e7935","DOI":"10.1097\/MD.0000000000007935","article-title":"Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer","volume":"96","author":"Chavan","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.ygyno.2023.01.012_bb0045","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/AOG.0000000000001980","article-title":"Incidence and timing of thromboembolic events in patients with ovarian cancer undergoing neoadjuvant chemotherapy","volume":"129","author":"Greco","year":"2017","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.01.012_bb0050","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/ijgc-2019-000980","article-title":"Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer","volume":"30","author":"Salinaro","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2023.01.012_bb0055","doi-asserted-by":"crossref","unstructured":"S.K. Chokshi, J.P. Gaughan, L. Krill, Incidence and patient characteristics of venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer, J. Thromb. Thrombolysis 53 (1) 202\u2013207 (2021) (PMID: 34185227).","DOI":"10.1007\/s11239-021-02511-6"},{"issue":"1","key":"10.1016\/j.ygyno.2023.01.012_bb0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2021.07.030","article-title":"Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy","volume":"163","author":"Basaran","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2023.01.012_bb0065","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1111\/aogs.14246","article-title":"Venous thromboembolism in women with ovarian cancer undergoing neoadjuvant chemotherapy prior to cytoreductive surgery: a retrospective study","volume":"100","author":"Oxley","year":"2021","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"12","key":"10.1016\/j.ygyno.2023.01.012_bb0070","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.jogc.2021.05.010","article-title":"Venous thromboembolism in patients receiving neoadjuvant chemotherapy for advanced ovarian cancer and impact on survival","volume":"43","author":"Black","year":"2021","journal-title":"J. Obstet. Gynaecol. Can."},{"issue":"10","key":"10.1016\/j.ygyno.2023.01.012_bb0075","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood."},{"issue":"11","key":"10.1016\/j.ygyno.2023.01.012_bb0080","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.6004\/jnccn.2018.0084","article-title":"NCCN guidelines insights: cancer-associated venous thromboembolic disease, version 2.2018","volume":"16","author":"Streiff","year":"2018","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"8","key":"10.1016\/j.ygyno.2023.01.012_bb0085","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1814468","article-title":"Apixaban to prevent venous thromboembolism in patients with cancer","volume":"380","author":"Carrier","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ygyno.2023.01.012_bb0090","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa1814630","article-title":"Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer","volume":"380","author":"Khorana","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2023.01.012_bb0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.thromres.2016.12.002","article-title":"Reciprocal links between venous thromboembolism, coagulation factors and ovarian cancer progression","volume":"150","author":"Swier","year":"2017","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.ygyno.2023.01.012_bb0100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1055\/s-0036-1597281","article-title":"Risk assessment scores for cancer-associated venous thromboembolic disease","volume":"43","author":"Angelini","year":"2017","journal-title":"Semin. Thromb. Hemost."},{"issue":"1","key":"10.1016\/j.ygyno.2023.01.012_bb0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ygyno.2011.11.025","article-title":"Have racial disparities in ovarian cancer increased over time? An analysis of SEER data","volume":"125","author":"Terplan","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"Suppl. 4","key":"10.1016\/j.ygyno.2023.01.012_bb0110","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0049-3848(09)70136-7","article-title":"Effects of race and ethnicity on the incidence of venous thromboembolism","volume":"123","author":"White","year":"2009","journal-title":"Thromb. Res."},{"issue":"2 Pt 1","key":"10.1016\/j.ygyno.2023.01.012_bb0120","first-page":"429","article-title":"84: prevention of deep vein thrombosis and pulmonary embolism","volume":"110","author":"ACOG Practice Bulletin No","year":"2007","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.01.012_bb0125","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in nonorthopedic surgical patients","volume":"141(2)2","author":"Gould","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ygyno.2023.01.012_bb0130","first-page":"Cd008500","article-title":"Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy","volume":"12","author":"Rutjes","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"10.1016\/j.ygyno.2023.01.012_bb0135","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/archsurg.141.8.790","article-title":"The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials","volume":"141","author":"Leonardi","year":"2006","journal-title":"Arch. Surg."},{"issue":"5","key":"10.1016\/j.ygyno.2023.01.012_bb0140","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/AOG.0b013e318232a394","article-title":"Venous thromboembolism prophylaxis in gynecologic surgery: a systematic review","volume":"118","author":"Ran","year":"2011","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.01.012_bb0145","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ygyno.2020.07.096","article-title":"Cost-effectiveness of apixaban for prevention of venous thromboembolic events in patients after gynecologic cancer surgery","volume":"159","author":"Glickman","year":"2020","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823000124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823000124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T20:50:24Z","timestamp":1715806224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823000124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":28,"alternative-id":["S0090825823000124"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.01.012","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the need for venous thromboembolism prophylaxis at the time of neoadjuvant chemotherapy for ovarian cancer: A literature review","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}